SWHR Testimony and Correspondence

SWHR regularly engages with members of Congress and congressional staff, the administration, and independent entities to raise awareness about diseases, conditions, and life stages that differently or disproportionately impact women as well as considerations specific to women that can be taken into account during policy development.

SWHR and Partners Send Letter Thanking Sens. Hyde-Smith and Peters for Introducing National Cholesterol Education Month Resolution

Twenty national organizations joined a sign-on letter led by the American Heart Association and the Society for Women’s Health Research...

SWHR Calls Attention to Women’s Health Research Opportunities in Letter to White House Initiative on Women’s Health Research

The Society for Women’s Health Research (SWHR) sent a letter to Dr. Carolyn Mazure, Chair of the White House Initiative...

SWHR Sends Welcome Letter to NIH Director Bertagnolli

The Society for Women’s Health Research (SWHR) sent a letter congratulating Monica Bertagnolli, MD, on her confirmation as Director of...

SWHR Submits Comments Re: Reforming NIH to Senate HELP Committee

The Society for Women’s Health Research (SWHR) responded to a September 2023 request for information from Senate Health, Education, Labor,...

SWHR Joins American Heart Association, Partners on Letter Thanking Sponsors of National Cholesterol Education Month Resolution

Sixteen national organizations joined a sign-on letter led by the American Heart Association and the Society for Women’s Health Research...

SWHR Thanks Women’s Caucus for Calling for Women’s Heart Health Prioritization

The Society for Women’s Health Research sent a letter thanking the Co-Chairs and Co-Vice Chairs of the Bipartisan Women’s Caucus...

SWHR Submits Comments to ICER on Proposed 2024 Value Assessment Framework

The Society for Women’s Health Research submitted comments to the Institute for Clinical and Economic Review (ICER) on its Methods...

SWHR Submits FY24 Outside Witness Testimony to LHHS Appropriations Subcommittee

SWHR submitted outside witness testimony to the House Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee with...

SWHR Provides Feedback to ICER on Draft Evidence Report on Treatments for Alzheimer’s Disease

SWHR provided feedback to the Institute for Clinical and Economic Review (ICER) in response to its Draft Evidence Report assessing...

SWHR Sends Letter Highlighting Legislative Priorities in Remainder of 117th Congress

The Society for Women’s Health Research (SWHR) sent a letter to House and Senate leadership urging both chambers to come...

SWHR Submits Letter to ICER on Draft Evidence Report for Fezolinetant

The Society for Women’s Health Research sent a letter to the Institute for Clinical and Economic Review (ICER) in response...

SWHR Provides Public Comments at NCCIH Stakeholder Meeting for Research on Whole-Person Health

The Society for Women’s Health Research provided public comments on October 18, 2022 during the National Center for Complementary and...

SWHR Sends Welcome Letter to NCI Director Bertagnolli

The Society for Women’s Health Research sent a letter to Monica M. Bertagnolli, MD, welcoming her to her new role...

SWHR Provides Input to Administration on Conference on Hunger, Nutrition, and Health

In response to the White House’s call for ideas and stories related to the Fall 2022 Conference on Hunger, Nutrition,...

SWHR Submits Letter to ICER on Draft Scoping Document for Fezolinetant

SWHR sent a letter to the Institute for Clinical and Economic Review (ICER) over its draft scoping document related to...

SWHR Submits FY 2023 Outside Witness Testimony

The Society for Women’s Health Research submitted outside witness testimony to the Senate Labor, Health and Human Services, Education and...

SWHR Submits Feedback on Draft Protocol of IVI’s Economic Model for MDD

The Society for Women’s Health Research provided feedback to the Innovation and Value Initiative on the draft protocol of its...

SWHR Comments to Congress on 21st Century Cures 2.0 Discussion Draft

SWHR President & CEO Kathryn G. Schubert submitted comments to Representatives Diana DeGette and Fred Upton in response to the...

SWHR Urges Congressional Leaders to Support Public Health Infrastructure Saves Lives Act

The Society for Women’s Health Research (SWHR) joined Trust for America’s Health and more than 200 other organizations in the...

SWHR Letter to ICER on Draft Evidence Report for Alzheimer’s Drug Aducanumab

In a letter to the Institute for Clinical and Economic Review (ICER), SWHR expressed concern over the methodology and conclusions...

SWHR Asks Congress to Prioritize Osteoporosis in FY22 Appropriations Bill

SWHR signed on to letters to Labor HHS Subcommittee leadership in the House and Senate with requests for the fiscal...

SWHR Urges Secretary Becerra to Prioritize Offices of Women’s Health

SWHR sent a letter urging Secretary of Health and Human Services (HHS) Xavier Becerra to prioritize the important work of...

SWHR Urges Congress to Prioritize Investments in Research Infrastructure

SWHR signed on to a letter urging Congressional leadership to include investments in the infrastructure underpinning the medical research enterprise...

SWHR Testimony on FY22 NIH Funding Priorities to House Appropriations Labor-HHS Subcommittee

As part of our efforts to support the National Institutes of Health (NIH) and to advance women’s health research, SWHR...

SWHR Congratulates Andrea Palm on Appointment as Deputy Secretary of HHS

SWHR sent a letter to Andrea Palm to congratulate her on her recent confirmation as Deputy Secretary for Health at...

SWHR Comments to Innovation and Value Initiative on Major Depressive Disorder Value Model Scope

SWHR President & CEO Kathryn G. Schubert submitted comments to the Innovation and Value Initiative (IVI) in response to their...

SWHR Urges Congress to Provide $100 Million for the Surveillance for Emerging Threats to Mothers and Babies Network

SWHR signed on to a letter urging Congress to provide $100 million for the Surveillance for Emerging Threats to Mothers...

SWHR Comments to NIH UNITE Initiative Committees on Diversity in Biomedical Careers

SWHR President & CEO Kathryn G. Schubert submitted comments to the National Institutes of Health UNITE Initiative Committees in response...

SWHR Congratulates Xavier Becerra on Appointment as Secretary of HHS

SWHR sent a letter to Xavier Becerra to congratulate him on his recent appointment as Secretary at the Department of...

SWHR Congratulates Dr. Rachel Levine on Appointment as Assistant Secretary of HHS

SWHR sent a letter to Dr. Rachel Levine to congratulate her on her recent appointment as Assistant Secretary for Health...

SWHR Urges President Biden to Champion the RISE Act

SWHR signed on to a letter, led by Research!America, encouraging President Joe Biden to champion the Research Investment to Spark...

SWHR Urges Congress to Include $750 Million in Funding for Title V MCH Block Grant

SWHR signed on to a letter urging Congress to support at least $750 million for the Title V Maternal and...

SWHR Urges Congress to Include $46.1 Billion in Funding for the NIH

SWHR President and CEO Kathryn G. Schubert sent a letter to Congressional leadership on the House and Senate Appropriations Subcommittees...

SWHR Congratulates Dr. Rochelle Walensky for Appointment as CDC Director

SWHR sent a letter to Dr. Rochelle Walensky to congratulate her on her recent appointment as Director of the Centers...

SWHR Asks ACIP to Continue Prioritizing Pregnant People in Recommendations for New COVID-19 Vaccine

SWHR signed onto a letter thanking the Advisory Committee on Immunization Practices (ACIP) at the Centers for Disease Control and...

SWHR Testimony on Future of Telehealth and Impact of COVID-19 Pandemic

This week, SWHR President and CEO Kathryn G. Schubert submitted testimony for the record to the House Energy & Commerce...

SWHR Urges Congress to Include $500 Million in Funding for AHRQ

SWHR signed onto a letter urging Congress to include no less than $500 million in funding for the Agency for...

SWHR Applauds President Biden’s Appointment of Dr. Janet Woodcock as Acting Commissioner of the FDA

The Society for Women’s Health Research sent a letter to President Joe Biden, thanking him for his recent appoint of...

SWHR Urges Congress to Complete Work on FY21 Appropriations

SWHR signed onto a letter with more than 170 organizations and institutions urging swift action to complete work on fiscal...

SWHR Urges President-Elect Biden to Prioritize NIH Funding

SWHR and nearly 350 other organizations signed onto a letter to President-Elect Biden discussing the importance of federal investment in...

SWHR Calls for Congressional Approval of Maternal Health Bills

In a push to see maternal health bills included in a year-end legislative package, SWHR signed onto a letter urging...

SWHR Calls on Congress to Strengthen Public Health Funding in FY21 Budget

SWHR joined more than 75 organizations in calling for strong funding for government public health and biomedical research agencies for...

SWHR Urges Congressional Leadership to Prioritize Endometriosis Research Funding

SWHR sent a letter to Congressional leadership in support of endometriosis’ inclusion as an eligible condition under the Department of...

SWHR Input to ICER on Assessment of New Alzheimer’s Disease Treatment

SWHR provided open input to the Institute for Clinical and Economic Review (ICER) on contextual considerations surrounding Alzheimer’s disease and...

SWHR Comments to NAM on COVID-19 Vaccine Allocation Framework

SWHR provided comments in response to the NAM “Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine...

SWHR Endorses AHRQ Funding Bill for Research on Critical Pandemic Health System Issues

SWHR and 95 other organizations signed on to a letter endorsing a bill to direct AHRQ to conduct or support...

SWHR Thanks HHS for Renewal of Public Health Emergency Declaration for COVID-19

SWHR thanks HHS for renewing the public health emergency declaration for the COVID-19 pandemic as urged in a previous sign-on...

SWHR Urges Funding of CDC’s Surveillance for Emerging Threats to Moms and Babies Program

SWHR signed on to a letter to Senate leadership requesting $100 million for the Surveillance for Emerging Threats to Moms...

SWHR Urges Inclusion of Expanded Pregnancy-Related Medicaid Coverage in COVID-19 Legislation

SWHR signed on to a letter urging Congressional leadership to include H.R. 4996, the Helping MOMS Act, in forthcoming COVID-19...

SWHR Calls on HHS to Address Structural Racism with Action on Section 1115 Demonstrations

SWHR and 279 other organizations called on HHS Secretary Alex Azar to address racial disparities and years of structural racism...

SWHR Urges Renewal of Public Health Emergency Declaration for COVID-19

SWHR signed on to a recent letter urging HHS to renew the public health emergency declaration for COVID-19 before it...

SWHR Applauds Work of PRGLAC Task Force

SWHR applauds the work of the PRGLAC task force in advising HHS on best practices to lessen knowledge gaps regarding safe...

SWHR Supports Uterine Fibroid Research and Education Act

SWHR signed onto a congressional letter of support for H.R. 6383, the Uterine Fibroid Research and Education Act of 2020.

SWHR Feedback to Senate HELP Committee Chair on Pandemic Preparedness Plan

SWHR stresses the importance of sex and gender as factors in pandemic response and preparedness in feedback on a Senate...

SWHR Urges Inclusion of At-Risk Women in COVID-19 Research

SWHR joined 25 organizations in urging the FDA and NIH to include certain groups of at-risk women in prioritized federal...

SWHR Testimony on HHS Appropriations for FY2021

SWHR CEO Kathryn G. Schubert provided testimony to the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and...

SWHR Comments on Cures 2.0 Legislation

SWHR provided Congress with initial feedback today in response to the recent concept paper addressing the bipartisan planned “Cures 2.0”...

SWHR Urges Inclusion of Pregnant and Lactating Women in COVID-19 Research

SWHR urged the NIH and FDA to include pregnant women and lactating women in all research for the development of...

SWHR Feedback to Senate Finance Health Subcommittee on Alzheimer’s Research Priorities

SWHR sent comments to the Senate Finance Subcommittee on Health Care in response to the its call for feedback related...

SWHR Urges Women’s Health Focus in U.S. Biotechnology Investment

In a letter to the White House Office of Science and Technology Policy (OSTP), SWHR recommended the government prioritize biotechnology...

SWHR Recommendations on ICER’s 2020 Value Assessment Framework

SWHR provided recommendations to the Institute for Clinical and Economic Review (ICER) on proposed changes to its 2020 value assessment...

SWHR Provides Input on ICER Value Assessment Framework

SWHR provided input to the Institute for Clinical and Economic Review (ICER) on the 2020 update to its value assessment...

SWHR Letter in Support of PRGLAC Task Force

In a letter to the Secretary of Health and Human Services, SWHR expresses its concerns about the future status of...

SWHR Calls for Robust NIH Funding for FY 2020

SWHR sent letters to the Senate and House subcommittees that oversee National Institutes of Health (NIH) funding urging increased investment...

SWHR Supports Women’s Health Research Day Resolution

SWHR sends letter to Sen. Duckworth (D-IL) and Rep. Schakowsky (D-IL-09) in acknowledgment of their resolutions recognizing Women’s Health Research...

SWHR Letter on Prioritization of Diagnostic Reform

SWHR joined a stakeholder letter to Congress calling for continued prioritization of diagnostic reform regarding LDTs and in vitro diagnostics.

SWHR Recommends ICER Delay Report on Endometriosis Treatments

SWHR provided comments to the Institute for Clinical and Economic Review (ICER) on its draft report assessing new endometriosis therapies.

SWHR Calls for Oversight on Clinical Laboratory Diagnostics

SWHR and stakeholder coalition send letter to Congressional committee leadership, focusing on the need for oversight for clinical laboratory diagnostics.

SWHR Input on ICER Migraine Therapies Draft Report

SWHR commented on ICER's migraine therapies draft report, regarding the effectiveness and value of calcitonin gene-related peptide (CGRP) inhibitors.

SWHR Urges ICER to Use Progressive Modeling to Assess Endometriosis Treatments

On February 1, 2018, SWHR submitted comments to the Institute for Clinical and Economic Review (ICER) before its assessment of...

SWHR Praises Resolution for Women’s Health Research Day

SWHR praises Sen. Duckworth and Rep. Schakowsky for their efforts in supporting Women's Health Research Day on January 25.

SWHR Urges ICER to Consider Disease Burden When Assessing Migraine Drugs

SWHR urged the Institute for Clinical and Economic Review (ICER) to incorporate the significant burden of migraine into its assessment...

SWHR Supports Continuation of FDA User Fee Programs

SWHR issued a letter supporting the continuation of the FDA user fee programs in order to guarantee sufficient scientific capacity...

Additional Policy and Advocacy Engagement

Check out more of SWHR’s efforts to bolster women’s health across the federal government.

View More